Tag: AONN+ conference
-
Genomic Testing for NSCLC: Insights from the AONN+ Conference for Oncology Navigators
Understanding genomic testing in NSCLC Genomic testing for non-small cell lung cancer (NSCLC) has evolved from a optional add-on to a cornerstone of personalized care. At the recent AONN+ conference, a focused session explored how oncology nurses, advanced practitioners, and navigators can effectively use biomarker testing to inform treatment decisions across NSCLC subtypes. The goal…
-
Genomic Testing for NSCLC: Session Highlights for Oncology Navigators
Overview: Why Genomic Testing Matters in NSCLC Genomic testing has become a cornerstone of precision care for non-small cell lung cancer (NSCLC). During a recent session at the AONN+ Conference, experts highlighted how oncology nurses, advanced practitioners, and navigators can use biomarker information to guide testing and treatment decisions. For patients with different NSCLC subtypes,…
-
New Insights for Lung Cancer Screening: AONN+ Conference Highlights Updated Guidelines
Overview of the AONN+ Conference Session The 16th Annual Academy of Oncology Nurse & Patient Navigators (AONN+) Conference recently featured a pivotal session focused on updated lung cancer screening guidelines and how clinicians and navigators can translate them into practice. With lung cancer continuing to be the leading cause of cancer deaths in the United…
-
AONN+ Conference Spotlight: Updated Lung Cancer Screening Guidelines and Practical Adherence Strategies
Introduction: Elevating Lung Cancer Screening Awareness Lung cancer remains the leading cause of cancer deaths in the United States, making effective screening strategies more important than ever. The 16th Annual Academy of Oncology Nurse & Patient Navigators (AONN+) Conference featured a pivotal session dedicated to updated lung cancer screening guidelines and practical approaches to boost…
-
Genomic Testing for NSCLC: Session at AONN+ Conference Delivers Insights for Oncology Navigators
Overview: Why Genomic Testing in NSCLC Matters for Navigators Genomic testing has become a cornerstone of non-small cell lung cancer (NSCLC) management. At the AONN+ conference, a dedicated session offered practical insights for oncology nurses, advanced practitioners, and navigators who guide patients through complex diagnostic and treatment pathways. The session emphasized that understanding which biomarker…